⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GRI News
GRI Bio, Inc. Common Stock
Form 8-K
sec.gov
GRI
GRI Bio Secures FDA Orphan Drug Designation for GRI-0621 (Tazarotene) in Idiopathic Pulmonary Fibrosis
globenewswire.com
GRI
Winner Medical Breaks Ground on New Production Base in Vietnam to Serve Global Medical Supply Chains Through Local Manufacturing
globenewswire.com
GRI
GRI Bio to Present at A.G.P.’s Annual Healthcare Company Showcase
globenewswire.com
GRI
Form 8-K
sec.gov
GRI
GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Immune-Modulating Pipeline
globenewswire.com
GRI
GRI Bio Receives Notice of Allowance for UAE Patent Application Covering Novel Type 2 Diverse NKT Cell Agonists for the Treatment of Inflammatory Conditions
globenewswire.com
GRI
AM Best Upgrades Credit Ratings for Members of Grange Insurance Group
businesswire.com
GRI
Goldgroup Named to TSXV List of Top 50 Performing Companies Ready to Announce with Confidence?
newsfilecorp.com
GRI
GRI Bio CEO, Marc Hertz, Featured in Virtual Investor “What This Means” Segment
globenewswire.com
GRI